Galcanezumab (Emgality, Eli Lilly and Co), the humanized monoclonal antibody that targets calcitonin gene–related peptide (CGRP), provides consistent improvements over time for patients with episodic ...

Most people experience headaches regularly and dismiss them as stress, dehydration, or simple tension. However, what feels like an ordinary headache could actually represent the early warning signs of ...

Cluster headache disorders constitute some of the most excruciating primary headache syndromes encountered in clinical practice. These conditions are typified by recurrent, strictly unilateral attacks ...

You’ve been treating your recurring headaches as migraines for months or years, taking migraine medications and avoiding triggers that don’t seem to help. But many people who think they have migraines ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

Please provide your email address to receive an email when new articles are posted on . Overall symptom burden was numerically higher in women than men. Women were more likely to report headaches, ...